NCT00717379View on ClinicalTrials.gov

Study of Tacrolimus Immunosuppressive Therapy After Kidney Transplantation

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
Kidney TransplantationKidney Failure, ChronicRenal Insufficiency, Chronic
Interventions
DRUG

Tacrolimus

oral

DRUG

Mycophenolate Mofetil

oral

DRUG

Methylprednisolone or equivalent

oral

DRUG

Prednisone

oral

Trial Locations (6)

115446

Moscow

119992

Moscow

123182

Moscow

197110

Saint Petersburg

404120

Volzskii

644112

Omsk

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY

NCT00717379 - Study of Tacrolimus Immunosuppressive Therapy After Kidney Transplantation | Biotech Hunter | Biotech Hunter